non-proliferative diabetic retinopathy
![Kodiak's Eye Drug Revival Spurs Renewed FDA Approval Bid](https://pharmtales.com/wp-content/uploads/2023/11/Kodiaks-Eye-Drug-Revival-Spurs-Renewed-FDA-Approval-Bid.jpg)
Kodiak’s Eye Drug Revival Spurs Renewed FDA Approval Bid
Anika Sharma
Kodiak Sciences had previously abandoned its tarcocimab tedromer program following disappointing results in two phase 3 trials. However, a recent ...